Treatment of Leukemia and Lymphoma in Children With Ataxia Telangiectasia

Key facts

Sponsor

Rabin Medical Center

Principal Investigator

Sarah Elitzur, MD

Schneider Children's Medical Center, Israel

Enrollment

250 enrolled

Eligibility

0-21 years · All sexes

Timeline

2019 – 2021

Study locations (1)

• Schneider Children's Medical Center, Petah Tikva, Israel

Collaborators

Israeli Society for Pediatric Hematology-Oncology · International BFM Study Group

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Ataxia-telangiectasia

Additional recruiting or active studies for the same condition.

• ACTIVE NOT RECRUITINGPHASE3NCT06673056
  A Pivotal Study of N-Acetyl-L-Leucine on Ataxia-Telangiectasia (A-T)
  IntraBio Inc
• ACTIVE NOT RECRUITINGPHASE2NCT04870866
  NAD Supplementation to Prevent Progressive Neurological Disease in Ataxia Telangiectasia
  University Hospital, Akershus

See all trials for Ataxia-telangiectasia →